Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.
Increase in opioid epidemic in the U.S. coupled with establishment of government policies to control the crisis is driving the market.
This report elaborates on the current development of the Opioid Use Disorder industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Indivior
Camurus
Titan Pharmaceuticals
Hikma Pharmaceuticals
Teva Pharmaceuticals
Alkermes
BioDelivery Sciences International Inc
MediciNova
Pfizer, Inc
Omeros
By Type:
Methadone
Buprenorphine
Naltrexone
By Application:
Moderate Pain Treatment
Severe Pain Treatment
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Opioid Use Disorder Market Overview 2018-2029
-
1.1 China Opioid Use Disorder Industry Development Overview
-
1.2 China Opioid Use Disorder Industry Development History
-
1.3 China Opioid Use Disorder Industry Market Size (2018-2029)
-
1.4 China Opioid Use Disorder Market Analysis by Type from Production Side
-
1.4.1 China Opioid Use Disorder Production Volume, Production Value and Growth Rate of Methadone (2018-2029)
-
1.4.2 China Opioid Use Disorder Production Volume, Production Value and Growth Rate of Buprenorphine (2018-2029)
-
1.4.3 China Opioid Use Disorder Production Volume, Production Value and Growth Rate of Naltrexone (2018-2029)
-
1.5 China Opioid Use Disorder Market Analysis by Application from Consumption End
-
1.5.1 China Opioid Use Disorder Sales Volume, Sales Value and Growth Rate of Moderate Pain Treatment (2018-2029)
-
1.5.2 China Opioid Use Disorder Sales Volume, Sales Value and Growth Rate of Severe Pain Treatment (2018-2029)
-
1.6 China Opioid Use Disorder Market Analysis by Region
-
1.6.1 North China Opioid Use Disorder Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Opioid Use Disorder Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Opioid Use Disorder Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Opioid Use Disorder Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Opioid Use Disorder Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Opioid Use Disorder Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Opioid Use Disorder Market Size and Growth Rate from 2018-2029
Chapter 2 China Opioid Use Disorder Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Opioid Use Disorder Market Status and Competition at home and abroad in 2023
-
2.2.2 China Opioid Use Disorder Market Status and Competition Analysis in 2023
-
2.2.3 China Opioid Use Disorder Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Opioid Use Disorder Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Opioid Use Disorder Industry Development
Chapter 3 Opioid Use DisorderIndustry Chain Analysis
-
3.1 Opioid Use Disorder Industry Chain
-
3.2 Opioid Use Disorder Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Opioid Use Disorder Market
-
3.3 Opioid Use Disorder Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Opioid Use Disorder Market
Chapter 4 China Opioid Use Disorder Market, by Type
-
4.1 China Opioid Use Disorder Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Opioid Use Disorder Total Production Volume and Growth Rate from Production Side
-
4.5 China Opioid Use Disorder Production Volume and Growth Rate, by Type
-
4.5.1 China Opioid Use Disorder Production Volume and Growth Rate of Methadone
-
4.5.2 China Opioid Use Disorder Production Volume and Growth Rate of Buprenorphine
-
4.5.3 China Opioid Use Disorder Production Volume and Growth Rate of Naltrexone
Chapter 5 China Opioid Use Disorder Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Opioid Use Disorder Total Market Size and Growth Rate from Consumption End
-
5.5 China Opioid Use Disorder Market Size and Growth Rate, by Application
-
5.5.1 China Opioid Use Disorder Market Size and Growth Rate of Moderate Pain Treatment
-
5.5.2 China Opioid Use Disorder Market Size and Growth Rate of Severe Pain Treatment
Chapter 6 China Opioid Use Disorder Market, by Region
-
6.1 China Opioid Use Disorder Production Volume and Production Value, by Region
-
6.2 China Opioid Use Disorder Sales Volume and Sales Value, by Region
Chapter 7 North China Opioid Use Disorder Market Analysis
-
7.1 North China Opioid Use Disorder Market, by Type
-
7.2 North China Opioid Use Disorder Market, by Application
Chapter 8 Central China Opioid Use Disorder Market Analysis
-
8.1 Central China Opioid Use Disorder Market, by Type
-
8.2 Central China Opioid Use Disorder Market, by Application
Chapter 9 South China Opioid Use Disorder Market Analysis
-
9.1 South China Opioid Use Disorder Market, by Type
-
9.2 South China Opioid Use Disorder Market, by Application
Chapter 10 East China Opioid Use Disorder Market Analysis
-
10.1 East China Opioid Use Disorder Market, by Type
-
10.2 East China Opioid Use Disorder Market, by Application
Chapter 11 Northeast China Opioid Use Disorder Market Analysis
-
11.1 Northeast China Opioid Use Disorder Market, by Type
-
11.2 Northeast China Opioid Use Disorder Market, by Application
Chapter 12 Southwest China Opioid Use Disorder Market Analysis
-
12.1 Southwest China Opioid Use Disorder Market, by Type
-
12.2 Southwest China Opioid Use Disorder Market, by Application
Chapter 13 Northwest China Opioid Use Disorder Market Analysis
-
13.1 Northwest China Opioid Use Disorder Market, by Type
-
13.2 Northwest China Opioid Use Disorder Market, by Application
Chapter 14 Company Profiles
-
14.1 Indivior
-
14.1.1 Indivior Company Profile
-
14.1.2 Indivior Opioid Use Disorder Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Camurus
-
14.2.1 Camurus Company Profile
-
14.2.2 Camurus Opioid Use Disorder Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Titan Pharmaceuticals
-
14.3.1 Titan Pharmaceuticals Company Profile
-
14.3.2 Titan Pharmaceuticals Opioid Use Disorder Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Hikma Pharmaceuticals
-
14.4.1 Hikma Pharmaceuticals Company Profile
-
14.4.2 Hikma Pharmaceuticals Opioid Use Disorder Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Teva Pharmaceuticals
-
14.5.1 Teva Pharmaceuticals Company Profile
-
14.5.2 Teva Pharmaceuticals Opioid Use Disorder Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Alkermes
-
14.6.1 Alkermes Company Profile
-
14.6.2 Alkermes Opioid Use Disorder Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 BioDelivery Sciences International Inc
-
14.7.1 BioDelivery Sciences International Inc Company Profile
-
14.7.2 BioDelivery Sciences International Inc Opioid Use Disorder Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 MediciNova
-
14.8.1 MediciNova Company Profile
-
14.8.2 MediciNova Opioid Use Disorder Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Pfizer, Inc
-
14.9.1 Pfizer, Inc Company Profile
-
14.9.2 Pfizer, Inc Opioid Use Disorder Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Omeros
-
14.10.1 Omeros Company Profile
-
14.10.2 Omeros Opioid Use Disorder Market Performance
-
14.10.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Opioid Use Disorder Industry Research Conclusions
-
15.2 Opioid Use Disorder Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Opioid Use Disorder Industry Market Size (2018-2029)
-
Figure China Opioid Use Disorder Production Volume, Production Value and Growth Rate of Methadone (2018-2029)
-
Figure China Opioid Use Disorder Production Volume, Production Value and Growth Rate of Buprenorphine (2018-2029)
-
Figure China Opioid Use Disorder Production Volume, Production Value and Growth Rate of Naltrexone (2018-2029)
-
Figure China Opioid Use Disorder Sales Volume, Sales Value and Growth Rate of Moderate Pain Treatment (2018-2029)
-
Figure China Opioid Use Disorder Sales Volume, Sales Value and Growth Rate of Severe Pain Treatment (2018-2029)
-
Figure North China Opioid Use Disorder Market Size and Growth Rate from 2018-2029
-
Figure Central China Opioid Use Disorder Market Size and Growth Rate from 2018-2029
-
Figure South China Opioid Use Disorder Market Size and Growth Rate from 2018-2029
-
Figure East China Opioid Use Disorder Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Opioid Use Disorder Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Opioid Use Disorder Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Opioid Use Disorder Market Size and Growth Rate from 2018-2029
-
Figure Opioid Use Disorder Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Opioid Use Disorder Market Share by Type in 2018
-
Figure China Opioid Use Disorder Market Share by Type in 2023
-
Figure China Opioid Use Disorder Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Opioid Use Disorder Production Volume and Growth Rate of Methadone (2018-2023)
-
Figure China Opioid Use Disorder Production Volume and Growth Rate of Buprenorphine (2018-2023)
-
Figure China Opioid Use Disorder Production Volume and Growth Rate of Naltrexone (2018-2023)
-
Figure China Opioid Use Disorder Market Share by Application in 2018
-
Figure China Opioid Use Disorder Market Share by Application in 2023
-
Figure China Opioid Use Disorder Total Market Size and Growth Rate from Consumption End
-
Figure China Opioid Use Disorder Market Size and Growth Rate of Moderate Pain Treatment (2018-2023)
-
Figure China Opioid Use Disorder Market Size and Growth Rate of Severe Pain Treatment (2018-2023)
-
Table China Opioid Use Disorder Production Volume by Region (2018-2023)
-
Table China Opioid Use Disorder Production Volume Share by Region (2018-2023)
-
Figure China Opioid Use Disorder Production Volume Share by Region (2018-2023)
-
Table China Opioid Use Disorder Production Value by Region (2018-2023)
-
Table China Opioid Use Disorder Production Value Share by Region (2018-2023)
-
Figure China Opioid Use Disorder Production Value Share by Region (2018-2023)
-
Table China Opioid Use Disorder Sales Volume by Region (2018-2023)
-
Table China Opioid Use Disorder Sales Volume Share by Region (2018-2023)
-
Figure China Opioid Use Disorder Sales Volume Share by Region (2018-2023)
-
Table China Opioid Use Disorder Sales Value by Region (2018-2023)
-
Table China Opioid Use Disorder Sales Value Share by Region (2018-2023)
-
Figure China Opioid Use Disorder Sales Value Share by Region (2018-2023)
-
Table North China Opioid Use Disorder Production Volume by Type (2018-2023)
-
Table North China Opioid Use Disorder Production Volume Share by Type (2018-2023)
-
Figure North China Opioid Use Disorder Production Volume Share by Type (2018-2023)
-
Table North China Opioid Use Disorder Sales Volume by Application (2018-2023)
-
Table North China Opioid Use Disorder Sales Volume Share by Application (2018-2023)
-
Figure North China Opioid Use Disorder Sales Volume Share by Application (2018-2023)
-
Table Central China Opioid Use Disorder Production Volume by Type (2018-2023)
-
Table Central China Opioid Use Disorder Production Volume Share by Type (2018-2023)
-
Figure Central China Opioid Use Disorder Production Volume Share by Type (2018-2023)
-
Table Central China Opioid Use Disorder Sales Volume by Application (2018-2023)
-
Table Central China Opioid Use Disorder Sales Volume Share by Application (2018-2023)
-
Figure Central China Opioid Use Disorder Sales Volume Share by Application (2018-2023)
-
Table South China Opioid Use Disorder Production Volume by Type (2018-2023)
-
Table South China Opioid Use Disorder Production Volume Share by Type (2018-2023)
-
Figure South China Opioid Use Disorder Production Volume Share by Type (2018-2023)
-
Table South China Opioid Use Disorder Sales Volume by Application (2018-2023)
-
Table South China Opioid Use Disorder Sales Volume Share by Application (2018-2023)
-
Figure South China Opioid Use Disorder Sales Volume Share by Application (2018-2023)
-
Table East China Opioid Use Disorder Production Volume by Type (2018-2023)
-
Table East China Opioid Use Disorder Production Volume Share by Type (2018-2023)
-
Figure East China Opioid Use Disorder Production Volume Share by Type (2018-2023)
-
Table East China Opioid Use Disorder Sales Volume by Application (2018-2023)
-
Table East China Opioid Use Disorder Sales Volume Share by Application (2018-2023)
-
Figure East China Opioid Use Disorder Sales Volume Share by Application (2018-2023)
-
Table Northeast China Opioid Use Disorder Production Volume by Type (2018-2023)
-
Table Northeast China Opioid Use Disorder Production Volume Share by Type (2018-2023)
-
Figure Northeast China Opioid Use Disorder Production Volume Share by Type (2018-2023)
-
Table Northeast China Opioid Use Disorder Sales Volume by Application (2018-2023)
-
Table Northeast China Opioid Use Disorder Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Opioid Use Disorder Sales Volume Share by Application (2018-2023)
-
Table Southwest China Opioid Use Disorder Production Volume by Type (2018-2023)
-
Table Southwest China Opioid Use Disorder Production Volume Share by Type (2018-2023)
-
Figure Southwest China Opioid Use Disorder Production Volume Share by Type (2018-2023)
-
Table Southwest China Opioid Use Disorder Sales Volume by Application (2018-2023)
-
Table Southwest China Opioid Use Disorder Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Opioid Use Disorder Sales Volume Share by Application (2018-2023)
-
Table Northwest China Opioid Use Disorder Production Volume by Type (2018-2023)
-
Table Northwest China Opioid Use Disorder Production Volume Share by Type (2018-2023)
-
Figure Northwest China Opioid Use Disorder Production Volume Share by Type (2018-2023)
-
Table Northwest China Opioid Use Disorder Sales Volume by Application (2018-2023)
-
Table Northwest China Opioid Use Disorder Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Opioid Use Disorder Sales Volume Share by Application (2018-2023)
-
Table Indivior Company Profile
-
Table Indivior Opioid Use Disorder Revenue, Price and Gross (2018-2023)
-
Table Camurus Company Profile
-
Table Camurus Opioid Use Disorder Revenue, Price and Gross (2018-2023)
-
Table Titan Pharmaceuticals Company Profile
-
Table Titan Pharmaceuticals Opioid Use Disorder Revenue, Price and Gross (2018-2023)
-
Table Hikma Pharmaceuticals Company Profile
-
Table Hikma Pharmaceuticals Opioid Use Disorder Revenue, Price and Gross (2018-2023)
-
Table Teva Pharmaceuticals Company Profile
-
Table Teva Pharmaceuticals Opioid Use Disorder Revenue, Price and Gross (2018-2023)
-
Table Alkermes Company Profile
-
Table Alkermes Opioid Use Disorder Revenue, Price and Gross (2018-2023)
-
Table BioDelivery Sciences International Inc Company Profile
-
Table BioDelivery Sciences International Inc Opioid Use Disorder Revenue, Price and Gross (2018-2023)
-
Table MediciNova Company Profile
-
Table MediciNova Opioid Use Disorder Revenue, Price and Gross (2018-2023)
-
Table Pfizer, Inc Company Profile
-
Table Pfizer, Inc Opioid Use Disorder Revenue, Price and Gross (2018-2023)
-
Table Omeros Company Profile
-
Table Omeros Opioid Use Disorder Revenue, Price and Gross (2018-2023)
-
